HOME >> MEDICINE >> NEWS
Studies provide new evidence on risks associated with Cox-2 inhibitors and NSAIDs

Two new review studies evaluating the safety of the pain-relieving medications selective cyclooxygenase 2 (COX-2) inhibitors and non-steroidal anti-inflammatory drugs (NSAIDs) find increased cardiovascular and kidney risks. The studies and an accompanying editorial were posted online today by JAMA because of the public health implications of the findings. The articles will appear in the October 4 print issue of JAMA.

"It is estimated that more than 30 million people worldwide take nonsteroidal anti-inflammatory drugs (NSAIDs) daily for treatment of pain and inflammation," according to background information provided in one of the articles. Adverse effects of some conventional NSAIDs include toxic gastrointestinal (GI) effects, as well as adverse renal (kidney) effects. "Overall, an estimated 2.5 million individuals in the United States annually experience adverse renal effects caused by use of NSAIDs," the authors write. "With decreased risk of adverse GI effects, a class of drugs that selectively inhibits COX-2 enzyme was introduced for analgesia (pain relief) and the treatment of arthritis." According to the authors, the adverse renal effects of selective COX-2 inhibition are unclear. Evidence is accumulating on the potential class effect of COX-2 inhibitors on cardiovascular risk. Two COX-2 inhibitors have already been withdrawn from the market: rofecoxib (marketed as Vioxx) and valdecoxib (marketed as Bextra).

Jingjing Zhang, M.D., Ph.D., from Brigham and Women's Hospital and Harvard Medical School, Boston, and colleagues evaluated the adverse risks of renal events and arrhythmia (disturbance of the normal heart rhythm) events in patients prescribed COX-2 inhibitors from a systematic review of the medical literature to determine if these negative side-effects involve every drug in this class.

"In this comprehensive meta-analysis of 114 randomized trials of COX-2 inhibitors comprised of 116,094 participants, rofecoxi
'"/>

Contact: Todd Datz
617-432-3952
JAMA and Archives Journals
12-Sep-2006


Page: 1 2 3 4 5

Related medicine news :

1. Studies show antidepressants not linked to birth defects
2. Studies show role of age, gender, race and weight on cancer risk and treatment
3. Studies suggest investigational agent reduces disease activity in MS
4. Studies highlight advances in diagnosis, medical therapy
5. Studies highlight real world use, safety of drug-eluting stents
6. Studies led by Rhode Island Hospital confirm safety and efficacy
7. Studies identify food sources of disease and drug resistance
8. Studies highlight need to monitor heart function in breast cancer patients
9. Studies examine physician disclosure of medical errors
10. Studies indicate medication can be an effective therapy for smoking cessation
11. Studies evaluating health effects of dental amalgam fillings in children confirm safety

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/12/2020)... (PRWEB) , ... August 12, 2020 , ... ... the company is under new ownership and looking to expand. , “Caring ... long-term staff members, but the franchise was underleveraged. As Caring Transitions, we can ...
(Date:8/11/2020)... ... August 11, 2020 , ... ... impairment, has announced the Best Memory Care Facilities in San Antonio, Texas. The ... features and amenities. , According to the Alzheimer’s Association , 5.6 ...
(Date:8/11/2020)... ... August 11, 2020 , ... "Deep Cover" star Laurence Fishburne is best known ... can add "host" to his repertoire with his role on TV's "In Depth" with ... around the world today. Soon the show will delve into the culture and health ...
(Date:8/11/2020)... ... August 11, 2020 , ... 2020 has seen a drastic change in how things ... CDC recommended that everyone wears a face mask in public. Now, most states have made ... , Earlier this year, all medical professionals in the U.S.A realized the shortage of ...
(Date:8/11/2020)... ... August 11, 2020 , ... ... unmet needs in the field of urology, today announced that Sean Delair, M.D., ... Excellence. The designation recognizes that Dr. Delair has achieved a high level of ...
Breaking Medicine News(10 mins):
(Date:8/5/2020)... ... August 04, 2020 , ... The Pulmonary Wellness Foundation (PWF), a New ... patients for nearly three decades, today announced the launch of the nation’s first online ... program kicked off Sunday, August 2 and meets on Wednesday and Sunday evenings at ...
(Date:8/3/2020)... Fla. (PRWEB) , ... August 03, 2020 , ... ... practice optimization solutions, is pleased to welcome Michelle Kopronica as their new Vice ... and a wealth of practice management knowledge in leading and developing teams and ...
(Date:8/3/2020)... and NEW YORK (PRWEB) , ... August 03, 2020 , ... ... on advancing health and science innovations, today announced that Donna L. LaVoie, President, CEO ... People in the life-sciences industry. , Since 2005, the PharmaVOICE 100 has ...
Breaking Medicine Technology:
Cached News: